Symptom control in care of the dying

Care of the Dying: A Pathway to Excellence

Volumn , Issue , 2011, Pages

  Glare, Paul ^a   Dickman, Andrew ^b   Goodman, Margaret ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

Author keywords

Ailments; Drugs; Dying; Liverpool care pathway for the dying patient; Skin; Symptom control; Symptoms

Indexed keywords

EID: 84920869350     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780199550838.003.0003     Document Type: Chapter

References (66)

1. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA1995;274:1591-8.
2. Ellershaw J, Foster A, Murphy D, et al. Developing an integrated care pathway for the dying patient. Eur J Palliat Care 1997;4:203-7.
3. Overill S. A practical guide to integrated pathways. J Integrated Care 1998;2:93-8.
4. Ellershaw J, Ward C. Care of the dying patient: the last hours or days of life. BMJ 2003;326:30-4.
5. Finucane TE. How gravely ill becomes dying: a key to end-of-life care. JAMA1999;282:1670-2.
6. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care 1990;6:7-15.
7. Turner K, Chye R, Aggarwal G, et al. Dignity in dying: a preliminary study of patients in the last three days of life. J Palliat Care 1996;12:7-13.
8. Nauck F, Klachik E, Ostgathe C. Symptom control during the last three days of life. Eur J Palliat Care 2001;10:81-4.
9. Ellershaw J. Care of the dying: what a difference an LCP makes! Palliat Med 2007;21:365-8.
10. Mullick A, Beynon T, Colvin M, et al. Liverpool care pathway carers survey. Palliat Med 2009;23:571-2.
11. Ellershaw J, Smith C, Overill S, et al. Care of the dying: setting standards for symptom control in the last 48 hours of life. J Pain Symptom Manage 2001;21:12-17.
12. Veerbeek L, van Zuylen L, Swart SJ, et al. The effect of the Liverpool Care Pathway for the dying: a multi-centre study. Palliat Med 2008;22:145-51.
13. Bookbinder M, Blank AE, Arney E, et al. Improving end-of-life care: development and pilot-test of a clinical pathway. J Pain Symptom Manage 2005;29:529-43.
14. Jarabek BR, Jama AA, Cha SS, et al. Use of a palliative care order set to improve resident comfort with symptom management in palliative care. Palliat Med 2008;22:343-9.
15. Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliat Med 2004;18:184-94.
16. Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000;160:786-94.
17. Breitbart W, Strout D. Delirium in the terminally ill. Clin Geriatr Med 2000; 16:357-72.
18. Goncalves JF, Alvarenga M, Silva A. The last forty-eight hours of life in a Portuguese palliative care unit: does it differ from elsewhere? J Palliat Med 2003;6:895-900.
19. Fainsinger R, Miller MJ, Bruera E, et al. Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991;7:5-11.
20. Grond S, Zech D, Schug SA, et al. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 1991;6:411-22.
21. Conill C, Verger E, Henriquez I, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage 1997;14:328-31.
22. Greaves J, Glare P, Kristjanson LJ, et al. Undertreatment of nausea and other symptoms in hospitalized cancer patients. Support Care Cancer 2009;17:461-4.
23. Twycross RG, Lack SA. Symptom control in far advanced cancer: pain relief. Pitman, London, 1983.
24. Virik K, Glare P. Pain management in palliative care. Reviewing the issues. Aust Fam Physician 2000;29:1027-33.
25. Lickiss JN. Approaching cancer pain relief. Eur J Pain 2001;5 Suppl A:5-14.
26. Twycross RG, Lack SA. Therapeutics in terminal cancer. Churchill Livingstone, Edinburgh, 1990.
27. Bruera E, Franco JJ, Maltoni M, et al. Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage 1995;10:287-91.
28. Eisele JH Jr, Grigsby EJ, Dea G. Clonazepam treatment of myoclonic contractions associated with high-dose opioids: case report. Pain 1992;49:231-2.
29. Bruera E, Sala R, Rico MA, et al. Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. J Clin Oncol 2005;23:2366-71.
30. Clary PL, Lawson P. Pharmacologic pearls for end-of-life care. Am Fam Physician 2009;79:1059-65.
31. Furst CJ, Doyle D. The terminal phase, in Doyle D, Hanks G, Cherny N, et al. (eds): Oxford textbook of palliative medicine. Oxford University Press, Oxford 2004, 1119-33.
32. Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G. The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain. 2009;13(4):331-8.
33. Portenoy RK, Sibirceva U, Smout R, et al. Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symptom Manage 2006;32:532-40.
34. Portenoy RK, Thomas J, Moehl Boatwright ML, et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, doseranging study. J Pain Symptom Manage 2008;35:458-68.
35. Agar M, Currow D, Plummer J, et al. Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches. Palliat Med 2009; 23:257-65.
36. Macleod AD. The management of delirum in hospice practice. Eur J Palliat Care 1997;4:116-20.
37. Breitbart W, Alici Y. Agitation and delirium at the end of life: 'We couldn't manage him'. JAMA 2008;300:2898-910, E1.
38. Spiller JA, Keen JC. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care. Palliat Med 2006;20:17-23.
39. Ventafridda V, Ripamonti C, De Conno F, et al. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990;6:7-11.
40. Fainsinger RL, De Moissac D, Mancini I, et al. Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Palliat Care 2000;16:5-10.
41. Rietjens JA, van Zuylen L, van Veluw H, et al. Palliative sedation in a specialized unit for acute palliative care in a cancer hospital: comparing patients dying with and without palliative sedation. J Pain Symptom Manage 2008;36:228-34.
42. Connor SR, Pyenson B, Fitch K, et al. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manage 2007;33:238-46.
43. McIver B, Walsh D, Nelson K, The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 1994;9:341-5.
44. Boettger S, Breitbart W. Atypical antipsychotics in the management of delirium: review of the empirical literature. Palliat Support Care 2005;3:227-37.
45. de Graeff A, Dean M. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med 2007;10:67-85.
46. Bennett MI. Death rattle: An audit of hyoscine (scopolamine) use and review of management. J Pain Symptom Manage 1996;12:229-33.
47. Ellershaw JE, Sutcliffe JM, Saunders CM. Dehydration and the dying patient. J Pain Symptom Manage 1995;10:192-97.
48. Wildiers H, Dhaenekint C, Demeulenaere P et al. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J Pain Symptom Manage. 2009;38(1):124-33.
49. Hugel H, Ellershaw J, Gambles M. Respiratory tract secretions in the dying patient: comparison between glycopyrronium and hyoscine hydrobromide. J Palliat Med 2006;9(2):279-84.
50. Wee B, Hillier R. Interventions for noisy breathing in patients near to death. Cochrane Database of Syst Rev. 2008; 1: CD005177. DOI: 10.1002/14651858.CD005177.pub2.
51. Hughes A, Wilcock A, Corcoran R, Lucas V, King A. Audit of three antimuscarinic drugs for managing retained secretions. Palliat Med 2000;14:221-22.
52. Doyle J, Walker P, Bruera E. Nebulized scopolamine. J Pain Symptom Manage. 2000;19:327-28.
53. Cranston JM, Crockett A, Currow D. Oxygen therapy for dyspnoea in adults. Cochrane Database of Systematic Reviews 2008; 3: CD004769. DOI: 10.1002/14651858.CD004769. pub2.
54. Viola R, Kiteley C, Lloyd NS et al. The management of dyspnea in cancer patients: a systematic review. Support Care Cancer 2008;16:329-37.
55. O'Doherty CA, Hall EJ, Schofield L, Zeppetella G. Drugs and syringe drivers: a survey of adult specialist palliative care practice in the United Kingdom and Eire. Palliat Med 2001;15:149-54.
56. Dickman A, Schneider J, Varga J. The Syringe Driver: Continuous Subcutaneous Infusions in Palliative Care. Second Ed Oxford University Press. Oxford. 2005.
57. de Graeff A, Dean M. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med 2007;10:67-85.
58. Morita T, Tsunoda J, Inoue S, Chihara S. Do hospice clinicians sedate patients intending to hasten death? J Palliat Care 1999;15(3): 20-23.
59. Gagnon PR. Treatment of delirium in supportive and palliative care. Curr Opin Support Palliat Care 2008;2(1):60-6.
60. Fürst and Doyle, D. (2005). In Oxford textbook of palliative medicine (ed. D. Doyle, G. Hanks, N. Cherny and K. Calman, Chapter 18. Oxford Medical Publications, Oxford.
61. Duxbury, A., Thakker, N., and Wastell, D. A double-blind crossover trial of a mucin containing artificial saliva. Br. Dent. J 1989;166;115-20.
62. Homes, S. Nursing management of oral care in older patients. Nurs. Times, 1996;92; 37-8.
63. Howarth, H. Mouth care procedures for the very ill. Nurs. Times, 1997;93;345-55.
64. Holmes, S. The oral complications of specific anticancer therapy. International Journal of Nursing, 1991;28,(4); 173-7.
65. Miller, M. and Kearney, N. Oral care for patients with cancer: A review of the literature. Cancer Nurs. 2001;24:241-4.
66. NICE (2005). The prevention and treatment of pressure ulcers. Guideline 29, National Institute for Health and Clinical Excellence www.nice.org/CG029.